Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Metabolomics: Taking Aim at Diabetic Kidney Failure

Published: Saturday, February 08, 2014
Last Updated: Saturday, February 08, 2014
Bookmark and Share
Krolewski and his Joslin colleagues search for better ways of predicting which diabetic people are at risk for ESRD.

My own research laboratory has worked on the genetics of diabetes for two decades. One of my colleagues from those early days, Andrzej Krolewski, a physician-scientist at the Joslin Diabetes Center in Boston, wondered why about one-third of people with type 2 diabetes eventually develop kidney damage that progresses to end-stage renal disease (ESRD), but others don’t. A stealthy condition that can take years for symptoms to appear, ESRD occurs when the kidneys fail, allowing toxic wastes to build up. The only treatments available are dialysis or kidney transplants.

It is known that rising levels of the protein albumin in the urine are a sign of kidney damage, but that seems to happen rather late in the process. So, Krolewski and his Joslin colleagues set about searching for better ways of predicting which people with diabetes are at risk for ESRD: information that could be used to develop new approaches to diagnosing, treating, and possibly even preventing this life-threatening complication.

In 1992, with NIH funding, the Joslin Study of the Genetics of Kidney Complications was launched; this was a prospective study in which relatively healthy volunteers with a recent diagnosis of type 2 diabetes were followed over the course of eight to 12 years. As part of the study, researchers periodically drew blood from participants and tracked their health status, hoping this information might someday prove useful in identifying markers in the blood associated with ESRD risk.

Now fast-forward to 2013. Monika Niewczas and others in Krolewski’s lab applied a more comprehensive approach to blood analysis called metabolomics, allowing sampling of a wide array of molecules.

The Joslin researchers used a device called a mass spectrometer to look for levels of about 2,400 metabolites in blood samples from two groups of volunteers: 40 who had developed ESRD over the course of the study and 40 who had not.

The researchers found that the first group had higher levels of 78 metabolites known to be elevated in ESRD than the second group. More importantly, 16 of these 78 metabolites were already elevated in the first group’s blood at the outset of the study-years before their first signs of ESRD appeared.

Among the metabolites most strongly associated with progression to ESRD were urate; a couple of phenyl compounds known to accumulate when kidney function declines; myo-inositol, a molecule involved in insulin signaling and a great many other biological processes; and pseudouridine, a molecule that is an indicator of RNA turnover in the body. These results were surprising because, until now, such metabolites were thought to accumulate only in late stages of the disease.

It remains to be determined whether these 16 metabolites are early biomarkers of kidney failure or might actually be contributing directly to the disease process. Additional work is also needed to assess the implications of the new findings for type 1 diabetes. To that end, the Joslin scientists and others are conducting genetic studies to explore whether there are some people with type 1 diabetes who are more susceptible to ESRD than others.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

NIH Study Finds Link Between Depression, Gestational Diabetes
Researchers at NIH have discovered that the depression in early pregnancy doubles risk for gestational diabetes, and gestational diabetes increases risk for postpartum depression.
Tuesday, September 20, 2016
Some Women With PCOS May Have Adrenal Disorder
Researchers at NIH have found that a subgroup of women with PCOS, a leading cause of infertility, may produce excess adrenal hormones.
Tuesday, June 28, 2016
Decoding Ties Between Vascular Disease, Alzheimer’s
NIH consortium uses big data, team science to uncover complex interplay of factors.
Tuesday, March 15, 2016
Newly Discovered Cells Restore Liver Damage in Mice Without Cancer Risk
The liver is unique among organs in its ability to regenerate after being damaged. Exactly how it repairs itself remained a mystery until recently, when researchers supported by the NIH discovered a type of cell in mice essential to the process
Monday, August 17, 2015
Study Finds Cutting Dietary Fat Reduces Body Fat More than Cutting Carbs
In a recent study, restricting dietary fat led to body fat loss at a rate 68 percent higher than cutting the same number of carbohydrate calories when adults with obesity ate strictly controlled diets.
Friday, August 14, 2015
Inappropriate Medical Food Use in Managing Patients with a Type of Metabolic Disorder
Researchers have proposed that there is a need for more rigorous clinical study of dietary management practices for patients with IEMs, including any associated long-term side effects, which may in turn result in the need to reformulate some medical foods.
Friday, August 14, 2015
Ease of Weight Loss Influenced by Individual Biology
NIH study finds varied responses to calorie restriction in obese adults.
Tuesday, May 12, 2015
Molecule Hijacks Enzyme To Boost Alcohol Metabolism
Study could lead to treatments for people with impaired acetaldehyde metabolism.
Tuesday, February 24, 2015
Underlying Genetics and Marker For Stroke Discovered
NIH-funded findings point to new potential strategies for disease prevention, treatment.
Friday, March 21, 2014
Speeding Validation of Disease Targets
NIH, industry and non-profits join forces to develop new treatments earlier, beginning with Alzheimer’s, type 2 diabetes, and autoimmune disorders.
Tuesday, February 04, 2014
Study to Examine if Vitamin D Prevents Diabetes
NIH-funded research will test the much-touted vitamin in people with prediabetes.
Monday, October 21, 2013
NIH Researchers Find Diabetes Drug Extends Health and Lifespan in Mice
Study was published in the July 30, 2013 issue of Nature Communications.
Thursday, September 05, 2013
Endocannabinoids Trigger Inflammation That Leads to Diabetes
NIH scientists identify possible treatment target for type 2 diabetes.
Thursday, August 22, 2013
Possible Treatment Target for Type 2 Diabetes Identified
Researchers at the NIH have clarified in rodent and test tube experiments the role that inflammation plays in type 2 diabetes, revealing a possible molecular target for treating the disease.
Tuesday, August 20, 2013
Diabetes Drug Extends Health and Lifespan in Mice
Long-term treatment with the type 2 diabetes drug metformin improves health and longevity of male mice when started at middle age.
Wednesday, July 31, 2013
Scientific News
Gene Deletion Reveals Cell Secrets
Researchers have deleted 174 genes in yeast to analyse the effect of individual gene deletion.
Targeting Fat to Treat Cancer
Researchers develop novel cancer treatment that halts fat synthesis in cells, stunting tumors.
NIH Study Finds Link Between Depression, Gestational Diabetes
Researchers at NIH have discovered that the depression in early pregnancy doubles risk for gestational diabetes, and gestational diabetes increases risk for postpartum depression.
Gut Pathogens Thrive on Body's Tissue-Repair Mechanism
Researcher have discovered that harm caused by pathogens in the intestinal tract benefit from immune system response to damaged intestinal lining.
Cancer's Taste for Fat
Researchers discovered signalling pathway for fat burning is disrupted in certain cancers.
‘Tracking Bugs’ Reveal Secret of Cancer Cell Metabolism
Unexpected finding shows instead of throwing away valuable nutrients, the cells squeeze out every last drop of energy.
Ginger Nano-Lipid Particles May Improve Cancer Treatment
Edible ginger-derived nano-lipids show promise for effectively targeting and delivering chemotherapeutic drugs used to treat colon cancer.
Genetic Diversity of Enzymes Alters Metabolic Individuality
ToMMo scientists have shown that genetic polymorphisms, structural location of mutation and effect for phenotype correlate with each other.
Absolute Quantification of Mitochondrial Metabolites
Scientists have developed a method to quickly isolate and systematically measure metabolite concentrations within mitochondria.
Vitamin C May Boost Leukemia Treatment
Studies show that supplementing an epigenetic cancer drug with vitamin C enhanced the drug's effectiveness.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!